Ignite Creation Date:
2025-12-25 @ 1:08 AM
Ignite Modification Date:
2025-12-27 @ 2:23 AM
Study NCT ID:
NCT01352793
Status:
COMPLETED
Last Update Posted:
2015-03-11
First Post:
2011-05-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-11
Start Date Type:
None
Primary Completion Date:
2014-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-09
Completion Date Type:
ACTUAL
First Submit Date:
2011-05-11
First Submit QC Date:
None
Study First Post Date:
2011-05-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-02-25
Results First Submit QC Date:
None
Results First Post Date:
2015-03-11
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-02-25
Last Update Post Date:
2015-03-11
Last Update Post Date Type:
ESTIMATED